Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
3.500
-0.250 (-6.67%)
At close: Nov 13, 2026, 4:00 PM EST
3.410
-0.090 (-2.57%)
After-hours: Nov 13, 2026, 4:41 PM EST
Starling Oncology Market Cap
Starling Oncology has a market cap or net worth of $356.97 million as of November 13, 2026. It is the 16,304th most valuable company in the world and the 2,923rd biggest in the United States. Its market cap has increased by 11.30% in one year.
Market Cap
356.97M
Enterprise Value
422.84M
1-Year Change
11.30%
Global Rank
Country Rank
#2,923 United States
Category
ChartMarket Cap Chart
Since July 23, 2021, Starling Oncology's market cap has increased from $990.00 to $356.97M, an increase of 36,057,332.73%. That is a compound annual growth rate of 1,011.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 356.97M | 1.92% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| U.S. Physical Therapy | 1.48B |
| AMN Healthcare Services | 1.46B |
| COMPASS Pathways | 1.31B |
| The Pennant Group | 1.29B |
| InnovAge Holding | 1.28B |
| Nutex Health | 1.28B |
| GMR Solutions | 993.48M |
| Strata Critical Medical | 537.71M |